James W. Traweek Jr., 10% Owner at REATA PHARMACEUTICALS INC (RETA), bought 40,218 shares at $183.00 ($7.4M) on 2019-11-18, disclosed to the SEC on 2019-11-18.
Open-market purchase of $7.4M RETA by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Negative factors outweigh the positive ones.
| Filing → |
| RETA | BUY | 2017-12-28 | $705K | — | Filing → |
| RETA | BUY | 2017-12-15 | $6.9M | — | Filing → |
| RETA | BUY | 2017-06-23 | $30.0M | — | Filing → |